6- ((6- fluoro- 3,4- dihydro- 2H- 1- benzopyran- 4- yl))oxy- N- (piperidin- 4- yl)pyrazin- 2- amine

structure in first source

Also Known As:

CBK201352

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	African Trypanosomiasis (Nagana) 02/01/2013 - "Thus, CBK201352 and related analogs are promising leads for the development of novel treatments for human African trypanosomiasis."
2.	Infections 02/01/2013 - "Mice inoculated intraperitoneally (i.p.) with 25 mg/kg CBK201352 twice daily for 10 days, starting on the day of infection with T. "